Clinically, high IL-18 levels in the circulation are purported to be predictors of cardiovascular mortality, ischemic stroke outcome, and a marker for insulin resistance (type 2) diabetes mellitus (DM) [9–11]. This evidence concerns the gene IL18 and type 2 diabetes mellitus.